Securities Code: 002432 Securities Abbreviation: Health Medical Announcement No.: 2026-023 Tianjin Health Medical Electronics Co., Ltd. Announcement on Proposed Application for Registration and Issuance of Debt Financing Instruments in the Interbank Market
The Company and the Board of Directors guarantee the truthfulness, accuracy, and completeness of the information disclosed, and are free from any false representations, misleading statements, or material omissions.
Tianjin Health Medical Electronics Co., Ltd. (hereinafter referred to as the "Company" or "this Company") held the fourth meeting of the seventh Board of Directors on April 28, 2026, and deliberated and passed the "Proposal on the Proposed Application for Registration and Issuance of Debt Financing Instruments in the Interbank Market."
To broaden financing channels and achieve broad coverage of investors such as financial institutions, and to secure funding for the Company's strategic layout, in accordance with the "Company Law of the People's Republic of China," the "Administrative Measures for Debt Financing Instruments of Non-financial Enterprises in the Interbank Bond Market," and other laws and regulations, combined with the Company's actual development needs, the Company intends to apply to the National Association of Financial Market Institutional Investors (hereinafter referred to as the "Bond Association") for registration and issuance of non-financial enterprise debt financing instruments (hereinafter referred to as "Debt Financing Instruments"), and to issue them either in a lump sum or in installments within the registered amount based on market conditions and the Company's capital needs. This matter is subject to the approval of the Company's shareholders.
I. Basic Plan for the Proposed Registration and Issuance of Debt Financing Instruments